Progressive Familial Intrahepatic Cholestasis in Korea: A Clinicopathological Study of Five Patients
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of autosomal recessive liver diseases that present as neonatal cholestasis. Little is known of this disease in Korea. Methods: The records of five patients histologically diagnosed with PFIC, one with PFIC1 and four with PFIC2, by liver biopsy or transplant were reviewed, and ATP8B1 and ABCB11 mutation status was analyzed by direct DNA sequencing. Clinicopathological characteristics were correlated with genetic mutations. Results: The first symptom in all patients was jaundice. Histologically, lobular cholestasis with bile plugs was the main finding in all patients, whereas diffuse or periportal cholestasis was identified only in patients with PFIC2. Giant cells and ballooning of hepatocytes were observed in three and three patients with PFIC2, respectively, but not in the patient with PFIC1. Immunostaining showed total loss of bile salt export pump in two patients with PFIC2 and focal loss in two. Lobular and portal based fibrosis were more advanced in PFIC2 than in PFIC1. ATP8B1 and ABCB11 mutations were identified in one PFIC1 and two PFIC2 patients, respectively. One PFIC1 and three PFIC2 patients underwent liver transplantation (LT). At age 7 months, one PFIC2 patient was diagnosed with concurrent hepatocellular carcinoma and infantile hemangioma in an explanted liver. The patient with PFIC1 developed steatohepatitis after LT. One patient showed recurrence of PFIC2 after 10 years and underwent LT. Conclusions: PFIC is not rare in patients with neonatal cholestasis of unknown origin. Proper clinicopathologic correlation and genetic testing can enable early detection and management.
Abstract
Background: Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of autosomal recessive liver diseases that present as neonatal cholestasis. Little is known of this disease in Korea. Methods: The records of five patients histologically diagnosed with PFIC, one with PFIC1 and four with PFIC2, by liver biopsy or transplant were reviewed, and ATP8B1 and ABCB11 mutation status was analyzed by direct DNA sequencing. Clinicopathological characteristics were correlated with genetic mutations. Results: The first symptom in all patients was jaundice. Histologically, lobular cholestasis with bile plugs was the main finding in all patients, whereas diffuse or periportal cholestasis was identified only in patients with PFIC2. Giant cells and ballooning of hepatocytes were observed in three and three patients with PFIC2, respectively, but not in the patient with PFIC1. Immunostaining showed total loss of bile salt export pump in two patients with PFIC2 and focal loss in two. Lobular and portal based fibrosis were more advanced in PFIC2 than in PFIC1. ATP8B1 and ABCB11 mutations were identified in one PFIC1 and two PFIC2 patients, respectively. One PFIC1 and three PFIC2 patients underwent liver transplantation (LT). At age 7 months, one PFIC2 patient was diagnosed with concurrent hepatocellular carcinoma and infantile hemangioma in an explanted liver. The patient with PFIC1 developed steatohepatitis after LT. One patient showed recurrence of PFIC2 after 10 years and underwent LT. Conclusions: PFIC is not rare in patients with neonatal cholestasis of unknown origin. Proper clinicopathologic correlation and genetic testing can enable early detection and management.
참고문헌 (28)
- Davit-Spraul A, "Progressive familial intrahepatic cholestasis", Orphanet J Rare Dis, 4, pp.1~ (2009)
- Jacquemin E., "Progressive familial intrahepatic cholestasis", Clin Res Hepatol Gastroenterol, 36(Suppl 1), pp.S26~S35 (2012)
- Clayton RJ, "Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred", Am J Dis Child, 117, pp.112~124 (1969)
- Bull LN, "A gene encoding a Ptype ATPase mutated in two forms of hereditary cholestasis", Nat Genet, 18, pp.219~224 (1998)
- Strautnieks SS, "A gene encoding a liverspecific ABC transporter is mutated in progressive familial intrahepatic cholestasis", Nat Genet, 20, pp.233~238 (1998)
- van Mil SW, "FIC1 disease : a spectrum of intrahepatic cholestatic disorders", Semin Liver Dis, 21, pp.535~544 (2001)
- Stapelbroek JM, "Liver disease associated with canalicular transport defects : current and future therapies", J Hepatol, 52, pp.258~271 (2010)
- Park YN, "Histological grading and staging of chronic hepatitis standardized guideline proposed by the Korean Study Group for the Pathology of Digestive Diseases", Korean J Pathol, 33, pp.337~346 (1999)
- Yu E, "Histologic grading and staging of chronic hepatitis: on the basis of standardized guideline proposed by the Korean Study Group for the Pathology of Digestive Diseases", Taehan Kan Hakhoe Chi, 9, pp.42~46 (2003)
- Nemesánszky E, "Gamma-glutamyltransferase and its isoenzymes : progress and problems", Clin Chem, 31, pp.797~803 (1985)
- Oude Elferink RP, "Hepatocanalicular transport defects : pathophysiologic mechanisms of rare diseases", Gastroenterology, 130, pp.908~925 (2006)
- Evason K, "Morphologic findings in progressive familial intrahepatic cholestasis 2(PFIC2) : correlation with genetic and immunohistochemical studies", Am J Surg Pathol, 35, pp.687~696 (2011)
- Alissa FT, "Update on progressive familial intrahepatic cholestasis", J Pediatr Gastroenterol Nutr, 46, pp.241~252 (2008)
- Morotti RA, "Progressive familial intrahepatic cholestasis(PFIC)type 1, 2, and 3 : a review of the liver pathology findings", Semin Liver Dis, 31, pp.3~10 (2011)
- Hori T, "Progressive familial intrahepatic cholestasis", Hepatobiliary Pancreat Dis Int, 9, pp.570~578 (2010)
- and Byler syndrome) : evidence for heterogeneity, "Hepatology", 1997, 155~164
- Emmanuel Gonzales, "Clinical utility gene card for: Progressive familial intrahepatic cholestasis type 1", European Journal of Human Genetics, 22(4), pp.572~572 (2014), Springer Science and Business Media LLC[DOI]
- Emmanuel Gonzales, "Clinical utility gene card for: Progressive familial intrahepatic cholestasis type 2", European Journal of Human Genetics, 22(4), pp.572~572 (2014), Springer Science and Business Media LLC[DOI]
- Klomp LW, "Characterization of mutations in ATP8B1 associated with hereditary cholestasis", Hepatology, 40, pp.27~38 (2004)
- Liu LY, "Characterization of ATP8B1 gene mutations and a hot-linked mutation found in Chinese children with progressive intrahepatic cholestasis and low GGT", J Pediatr Gastroenterol Nutr, 50, pp.179~183 (2010)
- Jacquemin E, "Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis", Hepatology, 25, pp.519~523 (1997)
- Amer S, "A comprehensive review of progressive familial intrahepatic cholestasis(PFIC) : genetic disorders of hepatocanalicular transporters", Gastroenterology Res, 7, pp.39~43 (2014)
- Bustorff-Silva J, "Partial internal biliary diversion through a cholecystojejunocolonic anastomosis : a novel surgical approach for patients with progressive familial intrahepatic cholestasis : a preliminary report", J Pediatr Surg, 42, pp.1337~1340 (2007)
- Aydogdu S, "Liver transplantation for progressive familial intrahepatic cholestasis : clinical and histopathological findings, outcome and impact on growth", Pediatr Transplant, 11, pp.634~640 (2007)
- Hori T, "Progressive familial intrahepatic cholestasis : a single-center experience of living-donor liver transplantation during two decades in Japan", Clin Transplant, 25, pp.776~785 (2011)
- Englert C, "Liver transplantation in children with progressive familial intrahepatic cholestasis", Transplantation, 84, pp.1361~1363 (2007)
- Lykavieris P, "Progressive familial intrahepatic cholestasis type 1 and extrahepatic features : no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation", J Hepatol, 39, pp.447~452 (2003)
- Miyagawa-Hayashino A, "Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1after living donor liver transplantation", Liver Transpl, 15, pp.610~618 (2009)